Angina Pectoris
📧 Sign up to get email alerts when something new happens for Angina Pectoris.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-07-16FDA Approved: MATZIM LA — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for MATZIM LA (diltiazem hydrochloride) from Actavis Pharma, Inc.
-
FDA approval · 2024-07-15FDA Approved: NADOLOL — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for Nadolol from Amneal Pharmaceuticals NY LLC under ANDA 208832, confirming the continued approval …
-
FDA approval · 2024-07-11FDA Approved: NADOLOL — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved a supplemental application for Nadolol from Alembic Pharmaceuticals Limited, expanding access to this generic beta-blocker.
-
FDA approval · 2024-07-11FDA Approved: PROPRANOLOL HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for propranolol hydrochloride by Lannett Company, Inc., approving changes to the existing ANDA to su…
-
FDA approval · 2024-06-28FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (BluePoint Laboratories)
FDA approves a supplemental application for metoprolol succinate from BluePoint Laboratories to bring a generic version to market.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: Scottish COmputed Tomography of the HEART Trial [NA]
The Scottish Computed Tomography of the HEART Trial has completed. It involves patients with angina pectoris or coronary heart disease.
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: MCG for Suspected INOCA Confirmed by Thermodilution-Derived CFR
A completed clinical trial evaluating MCG for suspected INOCA, with diagnosis confirmed by thermodilution-derived coronary flow reserve.
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
Clinical trial update reporting safety and effectiveness results for the Orsiro sirolimus-eluting coronary stent system in patients with cor…
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: AI Algorithms in Prediction of ACS Based on Leukocyte Properties
This clinical trial entry shows recruiting status for a study evaluating AI algorithms that predict acute coronary syndrome using leukocyte …
-
CLINICAL_TRIALS research · 2024-04-23Clinical Trial Update: Efficacy and Safety of Shexiang Baoxin Pill in Patients With Ischemia With Non-Obstructive Coronary Artery [Phase 4]
Clinical trial update reporting on the efficacy and safety of Shexiang Baoxin Pill in ischemia with non-obstructive coronary artery disease …
-
FDA approval · 2024-04-23FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (FRESENIUS KABI USA, LLC)
FDA approved the original application for Verapamil hydrochloride as a generic drug, manufactured by Fresenius Kabi USA, LLC. Verapamil hydr…
-
EMA approval · 2024-04-10EMA Authorised: Ranexa (previously Latixa) (ranolazine) — Menarini International Operations Luxembourg S.A. (MIOL)
The EMA authorises Ranexa (ranolazine) for angina pectoris with MIOL as the marketing author holder.
-
FDA approval · 2024-03-29FDA Approved: ATENOLOL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Atenolol by Aurobindo Pharma Limited, granting approval of a generic version under the ANDA proc…
-
FDA approval · 2024-03-28FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application from Zydus Lifesciences Limited for Atenolol under ANDA 076900. This confirms approval of a gene…
-
FDA approval · 2024-03-28FDA Approved: ATENOLOL — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for atenolol from Unichem Pharmaceuticals USA, Inc., granting an additional approval related to the …
-
FDA approval · 2024-03-28FDA Approved: ATENOLOL — Supplemental Application (Ipca Laboratories Limited)
FDA approved a supplemental application for Atenolol by Ipca Laboratories Limited.
-
FDA approval · 2024-03-01FDA Approved: NADOLOL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Nadolol from Aurobindo Pharma Limited under ANDA201893.
-
FDA approval · 2024-02-20FDA Approved: NITROGLYCERIN — Supplemental Application (Advagen Pharma Ltd)
The FDA approved a supplemental application for nitroglycerin from Advagen Pharma Ltd under an ANDA, enabling marketing of the generic produ…
-
FDA approval · 2024-02-16FDA Approved: NITROGLYCERIN — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approves Cosette Pharmaceuticals' generic nitroglycerin under an original ANDA.
-
FDA approval · 2024-02-05FDA Approved: NADOLOL — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Nadolol submitted by Zydus Pharmaceuticals USA Inc., resulting in updated labeling and/or indica…
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial) [Phase 1, Phase 2]
Clinical trial update on epicardial delivery of XC001 gene therapy for refractory angina in the EXACT trial (Phase 1/2), completed to date.
-
FDA approval · 2024-01-18FDA Approved: BISOPROLOL FUMARATE — Original Application (Harman Finochem Limited)
FDA approved Harman Finochem Limited's bisoprolol fumarate as an original generic application (ANDA). Bisoprolol fumarate is a beta-blocker …
-
FDA approval · 2023-12-22FDA Approved: TENORMIN — Supplemental Application (Almatica Pharma LLC)
FDA approves a supplemental application for Tenormin (atenolol) filed by Almatica Pharma LLC.
-
FDA approval · 2023-12-05FDA Approved: NITROGLYCERIN — Original Application (Lifestar Pharma LLC)
FDA approved an original application for nitroglycerin from Lifestar Pharma LLC, enabling a generic nitroglycerin product.
-
FDA approval · 2023-11-22FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for metoprolol tartrate from Aurobindo Pharma Limited. The action confirms approval of changes to an…